Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies

OBJECTIVE: Patients with anti-Jo-1 antibodies (Abs) and anti–melanoma differentiation-associated protein 5 (MDA5) Abs are at a higher risk of interstitial lung disease (ILD) and have a mortality rate higher than that of patients with anti-Jo-1 Abs. This study investigated differences in the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chao-Han, Kor, Chew-Teng, Hung, Ming-Hui, Hsiao, Kai-Hung, Cheng, Yen-Huang, Tien, Ya-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833901/
https://www.ncbi.nlm.nih.gov/pubmed/36644539
http://dx.doi.org/10.1155/2023/2988422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833901/
https://www.ncbi.nlm.nih.gov/pubmed/36644539
http://dx.doi.org/10.1155/2023/2988422

Ejemplares similares